Zesiger Capital

Total investments

7

Average round size

40M

Portfolio companies

6

Lead investments

1

Follow on index

0.14

Exits

2

Stages of investment
Late Stage Venture
Areas of investment
BiotechnologyE-CommerceInternetSoftwareHealth CareGeneticsPharmaceuticalComputerHardwareCommunications Infrastructure

Summary

The venture was found in North America in United States. The leading representative office of defined VC is situated in the New York.

The overall number of key employees were 2.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Computer, E-Commerce. Among the most popular portfolio startups of the fund, we may highlight Perlegen Sciences, Response Networks, LogMatrix.

The standard case for the fund is to invest in rounds with 8-9 partakers. Despite the Zesiger Capital, startups are often financed by Unilever Ventures, SB Life Science, Maverick Ventures. The meaningful sponsors for the fund in investment in the same round are Unilever Ventures, Sano Ventures, SB Life Science. In the next rounds fund is usually obtained by Versant Ventures, Unilever Ventures, T. Rowe Price.

The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars. This Zesiger Capital works on 4 percentage points more the average amount of lead investments comparing to the other organizations. The top amount of exits for fund were in 2010. The important activity for fund was in 2003. Speaking about the real fund results, this VC is 3 percentage points less often commits exit comparing to other organizations.

Show more

Investments analytics

Analytics

Total investments
7
Lead investments
1
Exits
2
Follow on index
0.14
Investments by industry
  • Biotechnology (4)
  • Pharmaceutical (4)
  • Health Care (3)
  • Genetics (2)
  • Communications Infrastructure (1)
  • Show 7 more
Investments by region
  • United States (7)
Peak activity year
2001

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
25
Avg. valuation at time of investment
9M
Group Appearance index
1.00
Avg. company exit year
16

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Cognetix 31 Jul 2001 Biotechnology, Medical, Pharmaceutical Early Stage Venture 17M Salt Lake City, Utah, United States

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.